Combined PET/MRI: a new dimension in whole-body oncology imaging?

被引：182

作者：

Antoch, Gerald ^{[1
]}

Bockisch, Andreas ^{[2
]}

机构：

[1] Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, D-45122 Essen, Germany

[2] Univ Duisburg Essen, Univ Hosp Essen, Dept Nucl Med, D-45122 Essen, Germany

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷

关键词：

PET; MRI; Whole-body oncology imaging; BREAST-CANCER; PET-CT; F-18-FDG PET/CT; LUNG-CANCER; FDG-PET; MRI; ACCURACY; MAMMOGRAPHY; TOMOGRAPHY; METASTASES;

D O I：

10.1007/s00259-008-0951-6

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

100231 [临床病理学]; 100902 [航空航天医学];

摘要：

Hybrid imaging systems providing morphological and functional data in a single session have been available for oncological imaging for some time. So far, computed tomography (CT) has been the morphological method-of-choice for inclusion into these hybrid imaging systems. However, recently, research has focused on hardware-based fusion of function with magnetic resonance imaging (MRI) rather than CT. Now that the first head-only positron emission tomography (PET)/MRI systems have been installed and whole-body systems are to be expected in the near future, potential indications in clinical oncology have to be addressed. This article discusses potential indications of PET/MRI in whole-body oncology imaging. Potential advantages and disadvantages compared with currently available hybrid imaging systems will be reviewed.

引用

页码：113 / 120

页数：8

共 38 条

[1]

Antoch G, 2005, J NUCL MED, V46, P520

[2]

Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: Comparison with CT and PET [J].

Antoch, G ;

Saoudi, N ;

Kuehl, H ;

Dahmen, G ;

Mueller, SP ;

Beyer, T ;

Bockisch, A ;

Debatin, JF ;

Freudenberg, LS .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (21) :4357-4368

[3]

Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology [J].

Antoch, G ;

Vogt, FM ;

Freudenberg, LS ;

Nazaradeh, F ;

Goehde, SC ;

Barkhausen, J ;

Dahmen, G ;

Bockisch, A ;

Debatin, JF ;

Ruehm, SG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (24) :3199-3206

[4]

Ba-Ssalamah Ahmed, 2007, Top Magn Reson Imaging, V18, P445, DOI 10.1097/rmr.0b013e3181614374

[5]

PET/CT for assessing mandibular invasion by intraoral squamous cell carcinomas [J].

Babin, E. ;

Desmonts, C. ;

Hamon, M. ;

Benateau, H. ;

Hitier, M. .

CLINICAL OTOLARYNGOLOGY, 2008, 33 (01) :47-51

[6]

Bar-Shalom R, 2003, J NUCL MED, V44, P1200

[7]

Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients [J].

Barentsz, Jelle O. ;

Futterer, Jurgen J. ;

Takahashi, Satoru .

EUROPEAN JOURNAL OF RADIOLOGY, 2007, 63 (03) :369-372

[8]

Collins Conor D, 2007, Cancer Imaging, V7 Spec No A, pS77, DOI 10.1102/1470-7330.2007.9008

[9]

Clinical and surgical staging of non-small cell lung cancer [J].

Deslauriers, J ;

Grégoire, J .

CHEST, 2000, 117 (04) :96S-103S

[10]

Eustace S J, 1999, Magn Reson Imaging Clin N Am, V7, P209

← 1 2 3 4 →